Germany
· Delayed Price · Currency is EUR Pentixapharm Holding AG Statistics
Total Valuation
FRA:PTP has a market cap or net worth of EUR 43.52 million. The enterprise value is 29.31 million.
| Market Cap | 43.52M |
| Enterprise Value | 29.31M |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 24.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 15.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -38.56 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 6.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.46 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.20 |
Financial Position
The company has a current ratio of 2.56
| Current Ratio | 2.56 |
| Quick Ratio | 2.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,398.50 |
Financial Efficiency
Return on equity (ROE) is -46.12% and return on invested capital (ROIC) is -20.62%.
| Return on Equity (ROE) | -46.12% |
| Return on Assets (ROA) | -14.99% |
| Return on Invested Capital (ROIC) | -20.62% |
| Return on Capital Employed (ROCE) | -32.16% |
| Revenue Per Employee | -17,633 |
| Profits Per Employee | -314,266 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 2.88 |
| Relative Strength Index (RSI) | 18.45 |
| Average Volume (20 Days) | 23,483 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:PTP had revenue of EUR -1.13 million and -20.11 million in losses. Loss per share was -0.81.
| Revenue | -1.13M |
| Gross Profit | -7.61M |
| Operating Income | -14.39M |
| Pretax Income | -24.20M |
| Net Income | -20.11M |
| EBITDA | -12.52M |
| EBIT | -14.39M |
| Loss Per Share | -0.81 |
Balance Sheet
The company has 14.21 million in cash and n/a in debt, giving a net cash position of 14.21 million.
| Cash & Cash Equivalents | 14.21M |
| Total Debt | n/a |
| Net Cash | 14.21M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.01M |
| Book Value Per Share | 1.65 |
| Working Capital | 9.91M |
Cash Flow
In the last 12 months, operating cash flow was -12.73 million and capital expenditures -608,000, giving a free cash flow of -13.34 million.
| Operating Cash Flow | -12.73M |
| Capital Expenditures | -608,000 |
| Free Cash Flow | -13.34M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 1,275.23% |
| Pretax Margin | 2,144.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.21% |
| Shareholder Yield | n/a |
| Earnings Yield | -46.22% |
| FCF Yield | -30.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:PTP has an Altman Z-Score of 3.32 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 3 |